228 related articles for article (PubMed ID: 32321997)
1. Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
Li MM; Chao E; Esplin ED; Miller DT; Nathanson KL; Plon SE; Scheuner MT; Stewart DR;
Genet Med; 2020 Jul; 22(7):1142-1148. PubMed ID: 32321997
[No Abstract] [Full Text] [Related]
2. Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Chao EC; Astbury C; Deignan JL; Pronold M; Reddi HV; Weitzel JN;
Genet Med; 2021 Jul; 23(7):1179-1184. PubMed ID: 33864022
[No Abstract] [Full Text] [Related]
3. Points to consider in the detection of germline structural variants using next-generation sequencing: A statement of the American College of Medical Genetics and Genomics (ACMG).
Raca G; Astbury C; Behlmann A; De Castro MJ; Hickey SE; Karaca E; Lowther C; Riggs ER; Seifert BA; Thorland EC; Deignan JL;
Genet Med; 2023 Feb; 25(2):100316. PubMed ID: 36507974
[No Abstract] [Full Text] [Related]
4. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
[No Abstract] [Full Text] [Related]
5. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Chung WK; Gordon AS; Herman GE; Klein TE; Stewart DR; Amendola LM; Adelman K; Bale SJ; Gollob MH; Harrison SM; Hershberger RE; McKelvey K; Richards CS; Vlangos CN; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1381-1390. PubMed ID: 34012068
[No Abstract] [Full Text] [Related]
6. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
[TBL] [Abstract][Full Text] [Related]
7. Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; Chao E; Gannon JL; Greely HT; Hagman KDF; Mao R; Topper S;
Genet Med; 2020 Aug; 22(8):1285-1287. PubMed ID: 32404921
[No Abstract] [Full Text] [Related]
8. Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
Rehder C; Bean LJH; Bick D; Chao E; Chung W; Das S; O'Daniel J; Rehm H; Shashi V; Vincent LM;
Genet Med; 2021 Aug; 23(8):1399-1415. PubMed ID: 33927380
[TBL] [Abstract][Full Text] [Related]
9. Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG).
Seaver LH; Khushf G; King NMP; Matalon DR; Sanghavi K; Vatta M; Wees K;
Genet Med; 2022 Mar; 24(3):512-520. PubMed ID: 35253645
[No Abstract] [Full Text] [Related]
10. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Gordon AS; Amendola LM; Adelman K; Bale SJ; Chung WK; Gollob MH; Harrison SM; Herman GE; Hershberger RE; Klein TE; McKelvey K; Richards CS; Vlangos CN; Stewart DR; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1391-1398. PubMed ID: 34012069
[No Abstract] [Full Text] [Related]
11. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
[No Abstract] [Full Text] [Related]
12. Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
David KL; Best RG; Brenman LM; Bush L; Deignan JL; Flannery D; Hoffman JD; Holm I; Miller DT; O'Leary J; Pyeritz RE;
Genet Med; 2019 Apr; 21(4):769-771. PubMed ID: 30578420
[No Abstract] [Full Text] [Related]
13. DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG).
Murray MF; Giovanni MA; Doyle DL; Harrison SM; Lyon E; Manickam K; Monaghan KG; Rasmussen SA; Scheuner MT; Palomaki GE; Watson MS;
Genet Med; 2021 Jun; 23(6):989-995. PubMed ID: 33727704
[No Abstract] [Full Text] [Related]
14. DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG).
Bean LJH; Scheuner MT; Murray MF; Biesecker LG; Green RC; Monaghan KG; Palomaki GE; Sharp RR; Trotter TL; Watson MS; Powell CM;
Genet Med; 2021 Jun; 23(6):979-988. PubMed ID: 33790423
[No Abstract] [Full Text] [Related]
15. Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; De Castro M; Horner VL; Johnston T; Macaya D; Maleszewski JJ; Reddi HV; Tayeh MK;
Genet Med; 2023 May; 25(5):100017. PubMed ID: 36799919
[No Abstract] [Full Text] [Related]
16. Correspondence on "Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)" by Hanson et al.
Stern RH
Genet Med; 2024 Feb; 26(2):101031. PubMed ID: 38156989
[No Abstract] [Full Text] [Related]
17. Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Matalon DR; Zepeda-Mendoza CJ; Aarabi M; Brown K; Fullerton SM; Kaur S; Quintero-Rivera F; Vatta M;
Genet Med; 2023 Jun; 25(6):100812. PubMed ID: 37058144
[No Abstract] [Full Text] [Related]
18. Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
Mao R; Krautscheid P; Graham RP; Ganguly A; Shankar S; Ferber M; Hegde M;
Genet Med; 2021 Oct; 23(10):1807-1817. PubMed ID: 34140662
[TBL] [Abstract][Full Text] [Related]
19. Correspondence on "Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)" by Riggs et al.
Spurdle AB; Drackley A; Ing A; Tudini E; Yap KL; Tavtigian SV
Genet Med; 2023 Aug; 25(8):100868. PubMed ID: 37261439
[No Abstract] [Full Text] [Related]
20. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]